TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
HBM Holdings Ltd. ( (HK:2142) ) just unveiled an announcement.
HBM Holdings Ltd. announced the successful completion of a share placement, raising funds through the issuance of 45,022,000 new shares at HK$11.50 each, representing 5.17% of the company’s enlarged share capital. The proceeds will be used to enhance research and development, advance clinical activities, upgrade the company’s innovation platform, and support general corporate purposes, positioning the company for growth in the biotechnology sector.
The most recent analyst rating on (HK:2142) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on HBM Holdings Ltd. stock, see the HK:2142 Stock Forecast page.
More about HBM Holdings Ltd.
HBM Holdings Ltd. is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. It is engaged in research and development activities, particularly in immunology and oncology, and offers innovative solutions from idea to IND for global partners.
Average Trading Volume: 11,510,297
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.38B
See more insights into 2142 stock on TipRanks’ Stock Analysis page.